Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$935M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$606M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$598M |
| 4 |
Alibaba
BABA
|
+$340M |
| 5 |
SPDR Gold Trust
GLD
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$47.4M |
| 2 |
Linde
LIN
|
+$29.9M |
| 3 |
Walmart Inc
WMT
|
+$28.5M |
| 4 |
Microsoft
MSFT
|
+$28.4M |
| 5 |
Deere & Co
DE
|
+$26.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 24.27% |
| 2 | Consumer Discretionary | 16.92% |
| 3 | Healthcare | 15.14% |
| 4 | Financials | 5.73% |
| 5 | Industrials | 3.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Edgewell Personal Care
EPC
$1.31B
| $3.4M | 0.02% |
93,795
+11,339
| +14% | +$466K |
|
352
Haemonetics
HAE
$4B
| $3.37M | 0.02% |
47,669
-4,236
| -8% | -$267K |
|
353
Viatris
VTRS
$18.9B
| $3.35M | 0.02% |
246,912
-49,828
| -17% | -$707K |
|
|
OCFT
354
DELISTED
OneConnect Financial Technology
OCFT
| $3.33M | 0.02% |
81,111
+63,699
| +366% | +$4.04M |
|
355
Levi Strauss
LEVI
$9.39B
| $3.32M | 0.02% |
+135,430
| New | +$3.65M |
|
356
Seaboard Corp
SEB
$4.06B
| $3.3M | 0.02% |
804
+127
| +19% | +$512K |
|
357
Open Text
OTEX
$6.04B
| $3.27M | 0.02% |
66,914
+20,264
| +43% | +$1.06M |
|
358
Usana Health Sciences
USNA
$286M
| $3.23M | 0.02% |
35,035
-1,495
| -4% | -$144K |
|
|
CVSA
359
Covista Inc
CVSA
$4.8B
| $3.23M | 0.02% |
85,323
-2,936
| -3% | -$109K |
|
360
Pembina Pipeline
PBA
$27.6B
| $3.21M | 0.02% |
+101,164
| New | +$3.19M |
|
|
NOAH
361
Noah Holdings
NOAH
$603M
| $3.2M | 0.02% |
86,235
+33,898
| +65% | +$1.34M |
|
362
Moderna
MRNA
$23.6B
| $3.2M | 0.02% |
+8,309
| New | +$3.06M |
|
363
Commerce Bancshares
CBSH
$8.5B
| $3.18M | 0.02% |
58,205
+7,214
| +14% | +$398K |
|
364
CorVel
CRVL
$3.19B
| $3.12M | 0.02% |
50,265
-4,620
| -8% | -$241K |
|
365
Gilead Sciences
GILD
$165B
| $3.12M | 0.02% |
44,619
-82,091
| -65% | -$5.77M |
|
366
Cal-Maine
CALM
$3.99B
| $3.09M | 0.02% |
85,569
-3,259
| -4% | -$116K |
|
|
CD
367
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $3.06M | 0.02% |
363,303
+285,327
| +366% | +$3.36M |
|
368
Strategic Education
STRA
$1.92B
| $3.04M | 0.02% |
43,115
-1,731
| -4% | -$129K |
|
369
Altria Group
MO
$114B
| $3.02M | 0.02% |
+66,271
| New | +$3.2M |
|
370
Boston Properties
BXP
$11.1B
| $3.02M | 0.02% |
27,829
-4,954
| -15% | -$566K |
|
371
Booking.com
BKNG
$161B
| $3M | 0.02% |
+31,550
| New | +$2.83M |
|
372
Cullen/Frost Bankers
CFR
$10.2B
| $2.98M | 0.02% |
25,133
+3,684
| +17% | +$411K |
|
373
Shopify
SHOP
$195B
| $2.97M | 0.02% |
21,910
+3,250
| +17% | +$487K |
|
374
AtriCure
ATRC
$2.11B
| $2.92M | 0.02% |
41,930
-1,494
| -3% | -$115K |
|
|
NUVA
375
DELISTED
NuVasive, Inc.
NUVA
| $2.9M | 0.02% |
48,430
-3,855
| -7% | -$238K |
|
Similar funds
Ray Dalio's Q3 2021 Portfolio in Review
As of Q3 2021, Ray Dalio held 821 positions worth $18.3B, up 17% from $15.6B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Ray Dalio deployed $3.42B of net new capital in Q3 2021, opening 117 new positions and adding to 343 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 8,990,211 shares worth $70M.
By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Danaher, an estimated $47.4M trimmed.
- Ray Dalio's largest Q3 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 8,990,211 shares worth $70M.
- Ray Dalio added most to iShares MSCI Emerging Markets ETF in Q3 2021, an estimated $935M increase.
- Ray Dalio's biggest Q3 2021 reduction was Danaher, cutting an estimated $47.4M.
- Ray Dalio fully exited Linde in Q3 2021, selling an estimated $29.9M.
- Ray Dalio's ten largest holdings make up 38% of its $18.3B portfolio in Q3 2021.
- Ray Dalio opened 117 new positions and closed 138 in Q3 2021.
- Ray Dalio's portfolio value rose 17% quarter-over-quarter to $18.3B.
Based on Bridgewater Associates's 13F filing for Q3 2021, filed 12 Nov 2021.